BRIEF published on 11/13/2025 at 16:10, 10 months 22 days ago The Vanguard Group Discloses Position in Avadel Pharmaceuticals Form 8.3 Disclosure Irish Takeover Panel Vanguard Group Avadel Pharmaceuticals
BRIEF published on 11/13/2025 at 16:10, 10 months 22 days ago Le groupe Vanguard révèle sa participation dans Avadel Pharmaceuticals Groupe Vanguard Divulgation Formulaire 8.3 Avadel Pharmaceuticals Panel Irlandais Des OPA
PRESS RELEASE published on 11/13/2025 at 16:09, 10 months 22 days ago Form 8.3 - The Vanguard Group, Inc.: Qualcomm Incorporated The Vanguard Group, Inc. discloses a 10.64% interest in Qualcomm Incorporated. Deals involving USD 0.0001 common stock include purchases and sales The Vanguard Group Financial Disclosure Interest Disclosure Stock Dealings Qualcomm Incorporated
BRIEF published on 11/13/2025 at 16:09, 10 months 22 days ago The Vanguard Group Files Disclosure on Mural Oncology plc Ordinary Shares Irish Takeover Panel Securities Disclosure Vanguard Mural Oncology
BRIEF published on 11/13/2025 at 16:09, 10 months 22 days ago Le groupe Vanguard publie des informations sur Mural Oncology plc Actions Ordinaires Avant-garde Information Sur Les Valeurs Mobilières Oncologie Murale Panel Irlandais Des OPA
PRESS RELEASE published on 11/13/2025 at 16:08, 10 months 22 days ago Form 8.3 - The Vanguard Group, Inc.: American Axle & Manufacturing Holdings, Inc. The Vanguard Group, Inc. discloses holding 7.47% interest in American Axle & Manufacturing Holdings, Inc. as of 12-Nov-2025 Securities Disclosure The Vanguard Group Interests American Axle & Manufacturing Holdings
BRIEF published on 11/13/2025 at 16:07, 10 months 22 days ago The Vanguard Group Discloses Position in Greencore Group Plc Takeover Code Securities Disclosure Vanguard Group Stock Position Greencore Group
BRIEF published on 11/13/2025 at 16:07, 10 months 22 days ago Le groupe Vanguard révèle sa participation dans Greencore Group Plc Groupe Vanguard Code De Prise De Contrôle Information Sur Les Valeurs Mobilières Groupe Greencore Position Boursière
PRESS RELEASE published on 11/13/2025 at 16:07, 10 months 22 days ago Form 8.3 - The Vanguard Group, Inc.: JTC plc The Vanguard Group, Inc. discloses its position of 5.06% in JTC plc. Details of the holdings and recent dealings provided in Form 8.3 Form 8.3 Position Disclosure The Vanguard Group Inc. Securities Dealing JTC Plc
PRESS RELEASE published on 11/13/2025 at 16:05, 10 months 22 days ago Form 8.3 - The Vanguard Group, Inc.: Avadel Pharmaceuticals plc The Vanguard Group, Inc. discloses a 5.67% stake in Avadel Pharmaceuticals plc as of 12 November 2025 under Form 8.3 with Irish Takeover Panel Form 8.3 Irish Takeover Panel Vanguard Group Stake Disclosure Avadel Pharmaceuticals Plc
Published on 10/05/2026 at 22:30, 11 hours ago EV Nickel Announces Formation of Wholly Owned Subsidiary to Advance Nickel Bioleaching Technology and Canadian Nickel Supply Chain
Published on 10/05/2026 at 14:45, 18 hours 45 minutes ago NanoViricides Provides Additional Details on the Phase II Clinical Trial of NV-387 Oral Gummies as a Treatment for Ebola as the Outbreak Continues to Expand and Has Taken Over 4,000 Lives
Published on 10/05/2026 at 14:30, 19 hours ago Hillcrest and Equipmake Expand Partnership Talks to Include Commercial Licensing of ZVS Technology
Published on 10/05/2026 at 14:30, 19 hours ago Solitario CEO to Present at John Tumazos Very Independent Research, LLC
Published on 10/05/2026 at 14:00, 19 hours 30 minutes ago Tectonic Metals Appoints Eduard Epshtein as CFO, Bolstering Executive Team for Next Stage of Growth
Published on 10/06/2026 at 09:09, 20 minutes ago Original-Research: Daldrup & Söhne AG (von Quirin Privatbank Kapitalmarktgeschäft): Buy
Published on 10/06/2026 at 09:05, 24 minutes ago The Platform Group Sells Stake in Platform for Beverage Machinery
Published on 10/06/2026 at 09:05, 24 minutes ago Bringin Introduces Euro Business Accounts for Companies Adopting Bitcoin, Without Taking Custody of Their Bitcoin
Published on 10/06/2026 at 09:05, 24 minutes ago Piramal Pharma Solutions Launches New Microbiology Laboratory at Its Lexington, KY Sterile Injectable Facility
Published on 10/06/2026 at 09:00, 29 minutes ago Original-Research: 029 Group SE (von NuWays AG): SELL
Published on 10/05/2026 at 22:12, 11 hours 17 minutes ago AXA - Elimination of the dilutive impact of Shareplan 2026
Published on 10/05/2026 at 22:12, 11 hours 17 minutes ago AXA - Elimination de l'effet dilutif de l'opération Shareplan 2026
Published on 10/05/2026 at 18:13, 15 hours 17 minutes ago Disclosure of shares outstanding and voting rights - 05.10.2026
Published on 10/05/2026 at 18:13, 15 hours 17 minutes ago Déclaration nombre d'actions et droits de vote - 05.10.2026
Published on 10/05/2026 at 18:00, 15 hours 30 minutes ago LANSON-BCC : Déclaration du nombre total des droits de vote et du nombre d’actions au 30 septembre 2026
